Cohnheim J. Über Entzündung und Eiterung. Pathol Anat Physiol Klin Med 1867; 40: 1-79.
Virchows VR. Editorial. Arch Pathol Anat Physiol Klin Med 1855; 3: 23.
Durante F. Nesso fisio-pathologico tra la struttura dei nei materni e la genesi di alcuni tumori maligni. Arch di Mem ed Osserv di Chir Prat 1874; 11: 217-26.
Zielins ER, Luan A, Brett EA, Longaker MT, Wan DC. Therapeutic applications of human adipose-derived stromal cells for soft tissue reconstruction. Discov Med 2015; 19(105): 245-53.
Katoh M. Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis. Stem Cell Rev 2007; 3(1): 30-8.
Li F, Zheng YY. Preparation method of lung cancer and tumor stem cells and application patent. CN109554347, 2019.
Jang YK, Kim MS. A pharmaceutical composition for inhibiting a growth of cancer stem cells comprising pyridine-based compound. KR20190001365, 2019.
Birkle S, Cochonneau D. Tartgeting O-acetylated GD2 gangliosides as a new therapeutic and diagnostic strategy for cancer stem cells. US2019023808, 2019.
Eavarone DA, Behrens J. Compositions and methods for targeting cancer stem cells. US2019031780, 2019.
Jin S, Mi L. Pharmaceutical composition for removing residual liver cancer stem cells with combined use of arsenic trioxide and all- transretinoic acid and application thereof. CN109288862, 2019.
Jabbari E. Drug delivery system and method for targeting cancer stem cells. US2019054034, 2019.
Tsunetomi R, Nagano H. Agents for reducing drug resistance in cancer stem cells, inhibitors of metastatic potency in cancer stem cells and methods for predicting metastatic recurrence risk of cancers. JP2019034940, 2019.
Hoque MO, Sidransky D. Pharmaceutical agents targeting cancer stem cells. US2019091202, 2019.
Замулаева ИА, Чурюкина КА. Method for reducing clonogenic activity of lacteal gland cancer stem cells. RU2019105663, 2019.
Lisanti M, Sotgia F. Mitoflavoscins: Targeting flavin-containing enzymes eliminates Cancer Stem Cells (CSCS) by inhibiting mitochondrial respiration. WO2019083997, 2019.
Yang R, Tang Q. A photosensitive nano-liposome targeting triple-negative breast cancer stem cells. CN109700765, 2019.
Soon SP, Niazi K. IL8 blocking EMT pathway and overcoming cancer stem cells. TW201922772, 2019.
Burzio ELO, Burzio MVA. Antisense oligonucleotides for treatment of cancer stem cells. HUE042738, 2019.
Kang SG, Chang JH. Pharmaceutical composition for inhibiting growth of cancer stem cells, containing aldehyde inhibitor and biguanide-based compound. US2019254995, 2019.
Cheresh D, Wettersten H. Compositions and methods for targeting and killing Alpha-V Beta-3-positive cancer stem cells (CSCs) and treating drug resistant cancers. AU2018243670, 2019.
Lisanti MS. "Energetic" Cancer Stem Cells (E-CSCS): A new hyper-metabolic and proliferative tumor cell phenotype, driven by mitochondrial energy. WO2019246173, 2019.
Smith R, Linda M, Huso D. Methods of inhibiting cancer stem cells with HMGA1 inhibitors. US2020009177, 2020.
Lisanti MP, Sotgia F. Antimitoscins: Targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells. AU2018270129, 2020.
Quinones HA, Green JCT. Nanoparticle modification of human adipose-derived mesenchymal stem cells for treating brain cancer and other neurological diseases. US2020038452, 2020.
Mehrpour M, Rodriguez R. Nitrogen-containing analogs of salinomycin, synthesis and use against cancer stem cells and malaria. PL3191493, 2020.